Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
[ad_1] Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and
Read More[ad_1] Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and
Read More[ad_1] There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health
Read More[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin
Read More[ad_1] For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring
Read More